PadoBiom®

The patented method for evaluating the gingival sulcus.

550 bacterial species

120 index bacteria

23 resistance genes

PadoBiom® analyzes the subgingival microbiome using a patented Next-Generation Sequencing (NGS) method, screening over 7,000 taxonomic classifications — including bacteria, fungi, viruses, and parasites — and approximately 550 oral bacterial species to calculate a Dysbiosis Index based on around 120 periodontitis- and health-associated bacteria.

The evaluated parameters also include 23 relevant antibiotic resistance genes across 6 antibiotic classes. In this process, the Dysbiosis Index assesses the balance between periodontitis- and health-associated bacteria. In addition, an algorithm calculates the dysbiosis progression risk, providing objective microbiological baseline data to assist clinicians in their overall patient evaluation.

Order your free PadoBiom® sampling set now.

Dysbiosis Index and Dysbiosis Progression Risk

Early laboratory detection of microbial dysbiosis for risk assessment

The ratio of health-associated to periodontitis-associated bacteria reflects the microbial balance within the periodontal pocket. The dysbiosis index makes shifts in the subgingival microbiome visible at the laboratory level—even before marked clinical symptoms appear.


Dysbiosis in the microbiome

Antibiotic resistance

Progression risk of dysbiosis

Detailed Assessment

COMPOSITION OF THE SUBGINGIVAL MICROBIOME
Bakterienverteilung Donut-Diagramm

Classification of bacteria into 4 categories (donut chart)

Health-associated / Periodontitis-associated / Core species / Other species

 
 

Indication of the number of bacterial species detected

Analysis of over 550 bacterial species

 
 

List of the most frequent bacteria from dysbiosis index + core species

Main contributing bacteria with a proportion > 0.1%

 
 

Periodontitis marker bacteria & Aa serotyping

Detection of pathogenic & highly pathogenic marker bacteria + Aa serotypes

 

Antibiotic resistance genes

MICROBIAL RISK FACTORS

The detection of resistance genes indicates an increased risk of diminished or absent efficacy for the affected antibiotics. Because genetic markers do not necessarily result in phenotypic expression, the laboratory report serves as an informative decision-making aid for dental treatment planning.

Benefits for Dental Practitioners

 

Use PadoBiom® as an objective decision-making aid to identify microbial dysbiosis at an early stage and precisely profile individual risks and relevant resistance genes in active periodontitis: